Xiao Zhi Selected Research

Xiao Zhi Research Topics

Disease

25	Neoplasms (Cancer) 07/2022 - 12/2012
11	Stomach Neoplasms (Stomach Cancer) 06/2018 - 01/2011
8	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 12/2012
5	Hypoxia (Hypoxemia) 07/2022 - 12/2014
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2015
2	Nervous System Diseases (Neurological Disorders) 12/2021 - 01/2021
2	Adenocarcinoma 01/2019 - 09/2015
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2016
2	Disease Progression 01/2017 - 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 07/2022
1	Triple Negative Breast Neoplasms 01/2022
1	COVID-19 12/2021
1	Stroke (Strokes) 01/2021
1	Ischemic Stroke 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Circulating Neoplastic Cells 01/2018
1	Teratoma (Teratoid Tumor) 01/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017

Drug/Important Bio-Agent (IBA)

9	GoldIBA 09/2021 - 05/2013
9	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 12/2012
8	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 08/2014
4	Therapeutic UsesIBA 12/2021 - 09/2015
4	MicroRNAs (MicroRNA)IBA 06/2018 - 01/2015
3	Peptides (Polypeptides)IBA 01/2022 - 01/2018
3	phytochlorinIBA 10/2018 - 01/2018
3	CytokinesIBA 01/2018 - 06/2015
2	Small Interfering RNA (siRNA)IBA 07/2022 - 01/2016
2	AntibodiesIBA 12/2021 - 12/2015
2	AntigensIBA 01/2020 - 12/2015
2	CarbohydratesIBA 01/2020 - 12/2015
2	degrasynIBA 11/2018 - 06/2015
2	Gemcitabine FDA Link 11/2018 - 09/2015
2	Photosensitizing Agents (Photosensitizers)IBA 10/2018 - 01/2018
2	SilverIBA 06/2018 - 05/2013
2	Biological ProductsIBA 01/2018 - 03/2016
2	OSI 027IBA 01/2017 - 09/2015
2	Silicon Dioxide (Silica)FDA LinkGeneric 12/2016 - 05/2013
2	LB100IBA 12/2014 - 08/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 08/2014
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2014 - 08/2014
1	Antisense RNA (Anti-Sense RNA)IBA 07/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2022
1	LTX-315IBA 01/2022
1	ElementsIBA 01/2022
1	LactoferrinIBA 01/2022
1	LigandsIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Viral RNAIBA 12/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	GlypicansIBA 09/2021
1	transgelinIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	TFXIBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Ubiquitin-Specific ProteasesIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 06/2018
1	aconitic anhydrideIBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2017
1	IonsIBA 01/2017
1	GadoliniumIBA 01/2017
1	Calcium Carbonate (Limestone)FDA Link 01/2017
1	Contrast MediaIBA 01/2017
1	Interleukin-2 (IL2)IBA 12/2016
1	Interleukin-17 (Interleukin 17)IBA 12/2016
1	Interleukin-12 (IL 12)IBA 12/2016
1	Interleukin-4 (Interleukin 4)IBA 12/2016
1	Interleukin-1 (Interleukin 1)IBA 12/2016
1	TRPC6 Cation ChannelIBA 03/2016
1	CalciumIBA 03/2016
1	Volatile Organic CompoundsIBA 01/2016
1	AMP-Activated Protein KinasesIBA 01/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	4-sulfophenylmethallyl ether (SPME)IBA 01/2016
1	VimentinIBA 01/2016
1	Carcinoembryonic AntigenIBA 12/2015
1	EnzymesIBA 12/2015
1	Helicobacter pylori cagA proteinIBA 12/2015
1	Pepsinogen A (Pepsinogen)IBA 12/2015
1	ImmunosorbentsIBA 12/2015
1	VaccinesIBA 06/2015
1	Combined VaccinesIBA 06/2015
1	CateninsIBA 04/2015
1	salinomycinIBA 04/2015
1	AlloysIBA 01/2014
1	Serum-Free Culture MediaIBA 01/2014

Therapy/Procedure

11	Therapeutics 11/2019 - 12/2012
6	Drug Therapy (Chemotherapy) 01/2020 - 08/2014
5	Immunotherapy 01/2022 - 06/2015
5	Precision Medicine 10/2018 - 01/2015
3	Lasers (Laser) 10/2018 - 02/2016
3	Photochemotherapy (Photodynamic Therapy) 01/2018 - 01/2016
3	Photothermal Therapy 01/2017 - 02/2016
1	Liver Transplantation 01/2017
1	Secondary Prevention 06/2015
1	Gastrectomy 01/2015